These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2677375)

  • 1. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension.
    Lewis RV; McLay J; Maclean D; Tregaskis B
    J Hum Hypertens; 1989 Aug; 3(4):233-7. PubMed ID: 2677375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the non-steroidal anti-inflammatory drugs, piroxicam or sulindac, on the antihypertensive actions of propranolol and verapamil.
    Baez MA; Alvarez CR; Weidler DJ
    J Hypertens Suppl; 1987 Dec; 5(5):S563-6. PubMed ID: 3481821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients.
    Chalmers JP; West MJ; Wing LM; Bune AJ; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1077-93. PubMed ID: 6378437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of indomethacin and sulindac with labetalol.
    Abate MA; Neely JL; Layne RD; D'Alessandri R
    Br J Clin Pharmacol; 1991 Mar; 31(3):363-6. PubMed ID: 2054279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.
    Pope JE; Anderson JJ; Felson DT
    Arch Intern Med; 1993 Feb; 153(4):477-84. PubMed ID: 8435027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac.
    Zambraski EJ; Dodelson R; Guidotti SM; Harnett CA
    Med Sci Sports Exerc; 1986 Dec; 18(6):678-84. PubMed ID: 3537627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of sulindac and indomethacin on the anti-hypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension.
    Koopmans PP; Thien T; Thomas CM; Van den Berg RJ; Gribnau FW
    Br J Clin Pharmacol; 1986 Apr; 21(4):417-23. PubMed ID: 3518773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin does not attenuate the hypotensive effect of trandolapril.
    Pritchard G; Lyons D; Webster J; Petrie JC; MacDonald TM
    J Hum Hypertens; 1996 Nov; 10(11):763-7. PubMed ID: 9004107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
    Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
    Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1.
    Johnson AG; Nguyen TV; Owe-Young R; Williamson DJ; Day RO
    J Hum Hypertens; 1996 Apr; 10(4):257-61. PubMed ID: 8736458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.